A detailed history of West Branch Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, West Branch Capital LLC holds 29,621 shares of ABBV stock, worth $5.24 Million. This represents 2.13% of its overall portfolio holdings.

Number of Shares
29,621
Previous 29,369 0.86%
Holding current value
$5.24 Million
Previous $5.04 Million 16.12%
% of portfolio
2.13%
Previous 1.96%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $41,287 - $50,231
252 Added 0.86%
29,621 $5.85 Million
Q2 2024

Jul 26, 2024

SELL
$154.79 - $180.76 $42,567 - $49,709
-275 Reduced 0.93%
29,369 $5.04 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $63,928 - $72,840
400 Added 1.37%
29,644 $5.4 Million
Q4 2023

Jan 19, 2024

BUY
$137.6 - $154.97 $15,548 - $17,511
113 Added 0.39%
29,244 $4.53 Million
Q3 2023

Oct 20, 2023

BUY
$133.59 - $154.65 $21,908 - $25,362
164 Added 0.57%
29,131 $4.34 Million
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $17,226 - $21,437
130 Added 0.45%
28,967 $3.9 Million
Q1 2023

Apr 20, 2023

SELL
$144.61 - $166.54 $289 - $333
-2 Reduced 0.01%
28,837 $4.6 Million
Q4 2022

Jan 27, 2023

SELL
$138.31 - $165.87 $276 - $331
-2 Reduced 0.01%
28,839 $0
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $4,294 - $4,925
-32 Reduced 0.11%
28,841 $3.87 Million
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $2,890 - $3,674
-21 Reduced 0.07%
28,873 $4.42 Million
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $31,147 - $38,645
-236 Reduced 0.81%
28,894 $4.68 Million
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $214 - $271
-2 Reduced 0.01%
29,130 $3.94 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $242,060 - $274,774
2,275 Added 8.47%
29,132 $3.14 Million
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $60,390 - $67,278
574 Added 2.18%
26,857 $3.03 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $93,195 - $102,596
-911 Reduced 3.35%
26,283 $2.84 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $4,748 - $6,411
-59 Reduced 0.22%
27,194 $2.91 Million
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $22,250 - $26,114
259 Added 0.96%
27,253 $2.39 Million
Q2 2020

Jul 08, 2020

BUY
$73.37 - $98.18 $32,943 - $44,082
449 Added 1.69%
26,994 $2.65 Million
Q1 2020

Apr 20, 2020

SELL
$64.5 - $97.79 $68,434 - $103,755
-1,061 Reduced 3.84%
26,545 $2.02 Million
Q4 2019

Jan 07, 2020

SELL
$72.13 - $90.25 $286,211 - $358,112
-3,968 Reduced 12.57%
27,606 $2.44 Million
Q3 2019

Oct 23, 2019

BUY
$62.98 - $75.72 $434,750 - $522,695
6,903 Added 27.98%
31,574 $2.39 Million
Q2 2019

Aug 05, 2019

SELL
$65.7 - $83.98 $311,418 - $398,065
-4,740 Reduced 16.12%
24,671 $1.79 Million
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $156,671 - $184,394
2,031 Added 7.42%
29,411 $2.37 Million
Q4 2018

Feb 07, 2019

SELL
$77.85 - $96.01 $62,824 - $77,480
-807 Reduced 2.86%
27,380 $2.52 Million
Q3 2018

Oct 16, 2018

SELL
$88.91 - $98.84 $130,075 - $144,602
-1,463 Reduced 4.93%
28,187 $2.67 Million
Q2 2018

Aug 02, 2018

BUY
$89.78 - $106.23 $303,007 - $358,526
3,375 Added 12.84%
29,650 $2.75 Million
Q1 2018

May 02, 2018

BUY
$92.01 - $123.21 $2.42 Million - $3.24 Million
26,275 New
26,275 $2.49 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track West Branch Capital LLC Portfolio

Follow West Branch Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Branch Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on West Branch Capital LLC with notifications on news.